Callan Family Office’s iShares S&P Mid-Cap 400 Growth ETF IJK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.2M Sell
78,333
-480
-0.6% -$53.3K 0.18% 107
2026
Q1
$7.93M Buy
78,813
+105
+0.1% +$10.8K 0.18% 114
2025
Q4
$7.63M Buy
78,708
+537
+0.7% +$51.7K 0.16% 119
2025
Q3
$7.5M Sell
78,171
-6,470
-8% -$610K 0.24% 86
2025
Q2
$7.7M Sell
84,641
-6,016
-7% -$515K 0.24% 89
2025
Q1
$7.55M Hold
90,657
0.57% 32
2024
Q4
$8.24M Sell
90,657
-1,200
-1% -$113K 0.52% 34
2024
Q3
$8.44M Buy
91,857
+388
+0.4% +$34.7K 1.42% 16
2024
Q2
$8.06M Hold
91,469
1.55% 16
2024
Q1
$8.35M Sell
91,469
-115
-0.1% -$9.59K 1.96% 11
2023
Q4
$7.26M Hold
91,584
1.79% 12
2023
Q3
$6.62M Buy
91,584
+33,317
+57% +$2.51M 1.76% 12
2023
Q2
$4.37M Buy
58,267
+18
+0% +$1.28K 1.15% 20
2023
Q1
$4.17M Buy
58,249
+19,028
+49% +$1.36M 1.01% 22
2022
Q4
$2.68M Buy
+39,221
New +$2.7M 0.86% 25

Other funds holding IJK

Callan Family Office's IJK Position: Q2 2026 in Review

Callan Family Office reduced its iShares S&P Mid-Cap 400 Growth ETF (IJK) stake by 0.61% in Q2 2026, selling an estimated $53.3K and leaving 78,333 shares worth $9.2M. The position accounts for 0.18% of the portfolio, ranked #107.

Callan Family Office first reported a position in IJK in Q4 2022 and has held it in 15 quarters since. 990 funds tracked by Wall St. Rank hold IJK as of Q2 2026.

  • Callan Family Office held 78,333 shares of iShares S&P Mid-Cap 400 Growth ETF worth $9.2M as of Q2 2026.
  • Callan Family Office sold 480 iShares S&P Mid-Cap 400 Growth ETF shares in Q2 2026, an estimated $53.3K.
  • iShares S&P Mid-Cap 400 Growth ETF made up 0.18% of Callan Family Office's portfolio in Q2 2026, its #107 holding.
  • Callan Family Office first reported a position in iShares S&P Mid-Cap 400 Growth ETF in Q4 2022 and has held it in 15 quarters since.
  • 990 funds tracked by Wall St. Rank held iShares S&P Mid-Cap 400 Growth ETF as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.